Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia

Blood Cells Mol Dis. 2021 May:88:102549. doi: 10.1016/j.bcmd.2021.102549. Epub 2021 Feb 20.

Abstract

Wilms tumor 1 (WT1) gene is commonly mutated in acute myeloid leukemia (AML), particularly in younger age population. The mechanism through which WT1 mutations drive leukemogenesis have not been fully elucidated; however, recent studies reported an association with the epigenetic pathway. Here, we studied the phenotypic characteristics and somatic mutational profile of 114 WT1-mutant AML patients and focused on potential WT1 gene relations to other cooperative genomic events that may impact disease prognosis. Invariant phenotypic and genomic associations of WT1 mutations in AML were uncovered and rigorously described. Our findings help improving the current understanding and definition of WT1-mutant AML patients' characteristics and clinical outcomes.

Keywords: Acute myeloid leukemia; Clinical associations; WT1 mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Middle Aged
  • Mutation
  • Prognosis
  • WT1 Proteins / genetics*
  • Young Adult

Substances

  • WT1 Proteins
  • WT1 protein, human